If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.55
Bid: 0.50
Ask: 0.60
Change: -0.02 (-3.51%)
Spread: 0.10 (20.00%)
Open: 0.575
High: 0.575
Low: 0.525
Prev. Close: 0.57
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

2 Aug 2023 14:29

RNS Number : 1044I
Bushveld Minerals Limited
02 August 2023
 

2 August 2023

Bushveld Minerals Limited

("Bushveld Minerals", "Bushveld" or the "Company")

Annual General Meeting Results

 

Bushveld Minerals Limited (AIM: BMN), the AIM quoted, integrated primary vanadium producer and energy storage provider, with ownership of high-grade assets in South Africa, announces that all ordinary resolutions put to shareholders at the Annual General Meeting held earlier today were duly passed.

 

No.

ORDINARY RESOLUTIONS

VOTES

IN FAVOUR

AGAINST

WITHHELD

1

To receive and adopt the Annual Financial Statements of the Company and the Directors report and the report of the Auditors for the financial year ended 31 December 2022.

98 533 384

90 204

1 397 262

2

To approve the Directors' fees as reflected in the Remuneration Report and in note 35 of the Annual Financial Statements.

94 251 126

4 821 496

948 228

3

That Messrs RSM UK Audit LLP be reappointed as Auditors to the Company.

98 407 596

565 752

1 047 502

4

That the Directors be authorised to approve the remuneration of the Company's Auditors.

98 188 877

785 554

1 046 419

5

That Michael Kirkwood shall be re-elected as a Director, having retired by rotation and offered himself for re-election.

93 991 307

4 407 531

1 622 012

6

That Kevin Alcock shall be re-elected as a Director, having retired by rotation and offered himself for re-election.

96 996 430

1 402 408

1 622 012

7

That Craig Coltman shall be re-elected as a Director in accordance with Article 140 of the Articles, having been appointed by the Directors in July 2023.

97 963 133

1 036 196

1 021 521

8

The Company be generally and unconditionally authorised for the purposes of Articles 50.3 of the Articles to make on market acquisitions (as defined in Article 50.5 of the Articles) of ordinary shares on such terms and in such manner as the Directors determine provided that:

(i) the maximum aggregate number of ordinary shares which may be purchased is 128,781,828 ordinary shares;

(ii) the minimum price (excluding expenses) which may be paid for each ordinary share is £0.01;

(iii) the maximum price (excluding expenses) which may be paid for any ordinary share does not exceed 105 percent of the average closing

price of such shares for the five business days of AIM prior to the date of purchase; and

(iv) this authority shall expire at the conclusion of the next Annual General Meeting of the Company unless such authority is renewed prior to that time (except in relation the purchase of Ordinary Shares the contract for which was concluded before the expiry of such authority, in which case such purchase may be concluded wholly or partly after such expiry).

97 900 593

733 945

1 386 312

9

The Directors of the Company be and are hereby authorised to exercise all powers of the Company to issue, grant rights to subscribe for, or to convert any securities into, up to 429,272,760 shares (together "Equity Securities") in the capital of the Company being approximately one- third of the issued share capital of the Company (excluding treasury shares) in accordance with Article 8.3 of the Articles of Incorporation of the Company such authority to expire, unless previously renewed, revoked or varied by the Company by ordinary resolution, at the end of the next Annual General Meeting of the Company or, if earlier, at the close of business on the date falling 15 months from the date of the passing of this Resolution, but in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require Equity Securities to be issued or granted after the authority given to the Directors of the Company pursuant to this

Resolution ends and the Directors of the Company may issue or grant Equity Securities under any such offer or agreement as if the authority given to the Directors of the Company pursuant to this Resolution had not ended. This Resolution is in substitution for all unexercised

authorities previously granted to the Directors of the Company to issue or grant Equity Securities; and

92 717 716

5 870 756

1 387 378

SPECIAL RESOLUTIONS

10

If Resolution 9 is passed, the Directors of the Company be and they are hereby authorised to exercise all powers of the Company to issue or grant Equity Securities in the capital of the Company pursuant to the issue or grant referred to in Resolution 9 as if the pre-emption rights contained in Article 9.9 of the Articles of Incorporation of the Company did not apply to such issue or grant provided that: (A) the maximum aggregate number of Equity Securities that may be issued or granted under this authority is 128,781,828 shares, being approximately 10.0 percent of the issued share capital of the Company (excluding treasury shares); and (B) the authority hereby conferred, unless previously renewed, revoked or varied by the Company by special resolution, shall expire at the end of the next Annual General Meeting of the Company or, if earlier, at the close of business on the date falling 15 months from the date of the passing of this Resolution, save that the Company may before such expiry make an offer or agreement which would or might require Equity Securities to be issued or granted after such expiry and the Directors may issue or grant Equity Securities in pursuance of such an offer or agreement as if the authority conferred by the above resolution had not expired. This Resolution is in substitution for all unexercised authorities previously granted to the Directors of the Company to issue or grant Equity Securities in the capital of the Company as if the pre-emption rights contained in Article 9.9 of the Articles of Incorporation of the Company did not apply to such issue or grant.

92 428 510

5 893 134

1 699 206

 

 

Enquiries: info@bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser & Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

 

Grant Baker / Richard Parlons

 

 

RBC Capital Markets

Joint Broker

+44 (0) 20 7653 4000

Jamil Miah / Sahil Suleman

 

 

Tavistock

Financial PR

Gareth Tredway / Tara Vivian-Neal/ James Whitaker

+44 (0) 207 920 3150

 

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a low-cost, vertically integrated primary vanadium producer. It is one of only three operating primary vanadium producers, owning 2 of the world's 4 operating primary vanadium processing facilities. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors, the Company participates in the entire vanadium value chain through its two main pillars: Bushveld Vanadium, which mines and processes vanadium ore; and Bushveld Energy, an energy storage solutions provider.

Bushveld Energy is focused on developing and promoting the role of vanadium in the growing global energy storage market through the advancement of vanadium-based energy storage systems, specifically Vanadium Redox Flow Batteries ("VRFBs").

 

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSEFDEEDSEEA
Date   Source Headline
6th Jan 20217:00 amRNSTotal Voting Rights
4th Jan 202111:34 amRNSHolding(s) in Company
18th Dec 20202:33 pmRNSPartial repayment of Duferco convertible loan note
30th Nov 20207:00 amRNSBushveld satisfies conditions of US$65m funding
27th Nov 20203:06 pmRNSGeneral meeting results
24th Nov 20207:00 amRNSQ3 and 9 months 2020 Operational Update
11th Nov 20207:00 amRNSVametco Mini-Grid Update
9th Nov 20207:01 amRNSCircular and Notice of GM
9th Nov 20207:00 amRNSSuccessful Raise of US$35M Convertible Loan Note
23rd Oct 202011:33 amRNSExchange Control Approval for Orion Transaction
19th Oct 20202:05 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:36 amRNSInterim Results for six months to end-June 2020
30th Sep 20207:13 amRNSFinancing with Orion and Convertible Loan Note
18th Sep 20202:37 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSVanadium Rental Partnership with Invinity
2nd Sep 20207:00 amRNSQ2 2020 and H1 2020 Operational Update
5th Aug 20203:18 pmRNSResult of AGM
3rd Aug 20207:00 amRNSInvestment in Enerox GmbH
21st Jul 202012:55 pmRNSDirector/PDMR Shareholding
30th Jun 202012:27 pmRNSPosting of accounts and notice of general meeting
23rd Jun 20208:58 amRNSFinal Results for the Year Ended 31 December 2019
14th May 202011:05 amRNSSecond Price Monitoring Extn
14th May 202011:00 amRNSPrice Monitoring Extension
11th May 20202:05 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSQ1 2020 Operational Update
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
14th Apr 202011:05 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
7th Apr 202011:05 amRNSSecond Price Monitoring Extn
7th Apr 202011:00 amRNSPrice Monitoring Extension
1st Apr 20203:51 pmRNSBushveld to hold 8.71% of newly created Invinity
24th Mar 20209:12 amRNSCovid-19 Update and Operation Halt
23rd Mar 202011:05 amRNSSecond Price Monitoring Extn
23rd Mar 202011:00 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSDirectorate Change
12th Mar 20202:06 pmRNSSecond Price Monitoring Extn
12th Mar 20202:00 pmRNSPrice Monitoring Extension
9th Mar 20204:41 pmRNSSecond Price Monitoring Extn
9th Mar 20204:36 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSJoint Venture agreement with redT
30th Jan 20209:17 amRNSFull Year 2019 and Q4 2019 Operational Update
19th Dec 20193:02 pmRNSUpdate on investment in Enerox GmbH ("Enerox")
12th Nov 20194:32 pmRNSPotential investment in Enerox GmbH
7th Nov 20197:01 amRNSBushveld Minerals Q3 2019 Operational Update
7th Nov 20197:00 amRNSVanchem Acquisition Completed
1st Nov 20199:46 amRNSStrategy for partnering with VRFB companies
1st Nov 20199:45 amRNSSupport for redT - Avalon Merger

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.